Adial Pharmaceuticals, Inc (ADIL) is a publicly traded Healthcare sector company. As of July 13, 2026, ADIL trades at $2.82 with a market cap of $6.08M and a P/E ratio of -0.24. ADIL moved +1.44% today. Year to date, ADIL is -50.48%; over the trailing twelve months it is -70.60%. Its 52-week range spans $1.31 to $32.50. Analyst consensus is buy with an average price target of $7.00. Rallies surfaces ADIL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for ADIL shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $2.82 |
| Market Cap | $6.08M |
| P/E Ratio | -0.24 |
| EPS | $-11.93 |
| Dividend Yield | 0.00% |
| 52-Week High | $32.50 |
| 52-Week Low | $1.31 |
| Volume | 52.21K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-7.98M |
| Gross Margin | 0.00% |
2 analysts cover ADIL: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.00.